Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Gynecologic Oncology|October 24, 2007
Randomized trial of pegylated liposomal doxorubicin (PLD) plus carboplatin versus carboplatin in platinum-sensitive (PS) patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of initial platinum-based chemotherapy (Southwest Oncology Group Protocol S0200)David S Alberts, P Y Liu, Sharon P Wilczynski, et al.
Investigational New Drugs|May 15, 2012
Investigation of bendamustine HCL in a phase 2 study in women with resistant ovarian cancerAmanda F Baker, Denise J Roe, Cynthia Laughren, et al.
Cancer Treatment and Research Communications|July 29, 2025
A systematic literature review of MTAP deletions in solid and hematologic CancersMary C Clouser, Mina Suh, Naimisha Movva, et al.
Gynecologic Oncology|March 4, 2008
Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: results from a prospectively designed analysis of progression-free survivalDavid S Alberts, Christian Marth, Ronald D Alvarez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
Phase I trial of intraperitoneal pemetrexed, cisplatin, and paclitaxel in optimally debulked ovarian cancerSetsuko K Chambers, H-H Sherry Chow, Mike F Janicek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2010
Overexpression of tumor vascular endothelial growth factor A may portend an increased likelihood of progression in a phase II trial of bevacizumab and erlotinib in resistant ovarian cancerSetsuko K Chambers, Mary C Clouser, Amanda F Baker, et al.
Pageof 3